Menu ×

HEALTHCARE & PHARMACEUTICAL

Necrotizing Ulcerative Gingivitis (NUG) Treatment Market Segmentation by Treatment {Medication (Antiseptic Ointments, Antibiotics, and Others), and Surgery (Gingival Grafting, and Others)}; by Distribution Channel (Hospitals, Homecare, Pharmacies, and Others) – Global Demand Analysis & Opportunity Outlook 2030

  • Text Size:

Extensive insights into the Growth of Necrotizing Ulcerative Gingivitis (NUG) Treatment Market amidst COVID-19

Before we witness the stabilization of economic growth in Europe and North America, Asia Pacific is estimated to bounce back progressively with countries such as China, India, South Korea and Japan witnessing more opportunities to recover from the losses sustained during COVID-19.

Being the biggest market in Eastern Europe, Russia is estimated to take the lowest hit, offering a sigh of relief to the businesses operating in the country. Whereas, GCC is estimated to observe low investments due to the sliding prices of crude oil.

We evaluate the strategies and commitment of the Giant Players in the market towards creating products and services that customers value and rely on.

In an attempt to control and eliminate the surge of coronavirus cases and meet the demand for required medical devices along with providing efficient medical services, there is a drastic shift of investments from authoritative bodies towards the healthcare sector. Where the aftermath of this pandemic may take years to be measured, Research Nester estimates notable expansion of e-health, gaming, and media and entertainment industries till the whole situation is contained and the plan of action for the recovery process is determined. There is an estimated probability of the growth in businesses going back a year if the condition is controlled in the next 2-3 months.                                                         Request Insights

Read More

IN THE NEWS

·    August, 2021: Cipla Limited to collaborate with biopharmaceutical contract development and manufacturing organization Kemwell Biopharma Private Limited to develop, manufacture and commercialize biosimilars for global markets.

·    May, 2021: Novartis AG plans to expand its antibiotic manufacturing business in Europe region, by investing 150 million Euro, i.e., over USD 175.93 million in new antibiotics manufacturing technology.

Global Necrotizing Ulcerative Gingivitis (NUG) Treatment Market Highlights over 2022 – 2030

The global necrotizing ulcerative gingivitis (NUG) treatment market is estimated to grow at a noteworthy CAGR over the forecast period, i.e., 2022 – 2030. The growth of the market can be attributed to the growing cases of necrotizing ulcerative gingivitis or NUG, especially amongst adults. The major causes of NUG include diet high in sugar, alcohol abuse, tobacco consumption in any form, and careless oral hygiene habits. Patients of diabetes are also at high risk of developing necrotizing ulcerative gingivitis. According to the data by the World Health Organization (WHO), diabetes caused 1.5 million deaths in 2019. The disease is characterized by ulcers in gums, and the lining between teeth, along with severe pain, bad breath, and bleeding in gums. Rising cases of oral diseases, and poor oral health are the primary factors estimated to drive the market growth. According to other statistics by the WHO, 3.5 billion people, which is nearly half of the global population, suffer from oral diseases. Almost 10% of the global population experiences gum-related problems, while 530 million children have cavities in their milk teeth. Lack of awareness regarding oral health is another major factor projected to boost the market growth.

Necrotizing Ulcerative Gingivitis (NUG) Treatment MarketConsumption of tobacco is a major concern amongst governments of various countries, as well as the health authorities, as tobacco is one of the foremost causes of immature death, and also leads to various severe diseases. According to other report by the WHO, 7 million deaths are caused by direct tobacco consumption, in the form of smoking and chewing tobacco.  Various government initiatives to curb the consumption of tobacco, have successfully lowered the share of population consuming tobacco. According to the data by the WHO, 7 million tobacco users increased between 2010 to 2015, while almost 2 million users have decreased between 2018 and 2020. However, tobacco consumption has significantly risen amongst adolescents between the age of 13 to 15 years. This, as a result, is estimated to increase the prevalence of NUG amongst adolescents, which is projected to boost the market growth.  CLICK TO DOWNLOAD SAMPLE REPORT

Tobacco

The market is segmented by treatment into medication, and surgery, out of which, the medication segment is anticipated to hold the largest share in the global necrotizing ulcerative gingivitis (NUG) treatment market over the forecast period on account of affordability of medication, and instant relief in symptoms. Moreover, majority cases are diagnosed at a stage where medications can be sufficient for complete treatment of NUG. As the disease is caused by infection, antiseptic, as well as, antibiotic drugs are effective against the symptoms.

Major Macro-Economic Indicators Impacting the Market Growth

Healthcare Expenditure

According to the statistics by the World Health Organization, the global per capita healthcare expenditure amounted to USD 1,064.741 in the year 2017. The worldwide healthcare expenditure per person grew from USD 864.313 in 2008 to USD 1,110.841 in 2018, where the U.S. is the top country that amounted to healthcare expenditure of USD 10, 623.85 per capita in 2018. As of 2018, the domestic general government healthcare spending in the U.S. was USD 5355.79, which grew from USD 3515.82 in 2008. These are some of the factors responsible for market growth over the past few years. Moreover, as per the projections by the Centers for Medicare & Medicaid Services (CMS), the estimated average annual percent change related to National Health Expenditures (NHE) in the U.S. was 5.2% in 2020 as compared to 2019 (4.5%). Furthermore, the National Health Expenditures are projected to reach USD 6,192.5 Billion in 2028, where the per capita expenditure is estimated to touch USD 17,611 in the same year. These are notable indicators that are anticipated to create lucrative business opportunities in upcoming years.

Global Necrotizing Ulcerative Gingivitis (NUG) Treatment Market Regional Synopsis

On the basis of geographical analysis, the global necrotizing ulcerative gingivitis (NUG) treatment market is segmented into five major regions including North America, Europe, Asia Pacific, Latin America and Middle East & Africa region. The market in the North America region is anticipated to gain the largest market share throughout the forecast period owing to the increasing prevalence of oral diseases in the developed countries, including the US, backed by poor diet, and high cases of diabetes amongst the people. According to the data by the Center of Disease Control and Prevention (CDC), more than 1 in every 4 adults, i.e., around 26% of the American population suffers with untreated tooth decay. Moreover, growing health awareness amongst the people and government initiatives to ensure efficient healthcare facilities, are estimated to boost the market growth. Besides this, the rising focus on the advancements in the diagnosis and treatment of different necrotizing gingivostomatitis diseases is also expected to drive the market growth.

The market in Asia Pacific region is estimated to witness noteworthy growth over the forecast period on the back of improving public healthcare system, and growing awareness amongst people regarding oral hygiene. 

Necrotizing Ulcerative Gingivitis (NUG) Treatment Market

The global necrotizing ulcerative gingivitis (NUG) treatment market is further classified on the basis of region as follows:

  • North America (U.S. & Canada) Market size, Y-O-Y growth, Market Players Analysis & Opportunity Outlook
  • Latin America (Brazil, Mexico, Argentina, Rest of Latin America) Market size, Y-O-Y growth & Market Players Analysis & Opportunity Outlook
  • Europe (U.K., Germany, France, Italy, Spain, Hungary, Belgium, Netherlands & Luxembourg, NORDIC(Finland, Sweden, Norway, Denmark), Ireland, Switzerland, Austria, Poland, Turkey, Russia, Rest of Europe), Poland, Turkey, Russia, Rest of Europe) Market size, Y-O-Y growth Market Players Analys & Opportunity Outlook
  • Asia-Pacific (China, India, Japan, South Korea, Singapore, Indonesia, Malaysia, Australia, New Zealand, Rest of Asia-Pacific) Market size, Y-O-Y growth & Market Players Analysis & Opportunity Outlook
  • Middle East and Africa (Israel, GCC (Saudi Arabia, UAE, Bahrain, Kuwait, Qatar, Oman), North Africa, South Africa, Rest of Middle East and Africa) Market size, Y-O-Y growth Market Players Analysis & Opportunity Outlook

Market Segmentation

Our in-depth analysis of the global necrotizing ulcerative gingivitis (NUG) treatment market includes the following segments:

By Treatment

  • Medication
    • Antiseptic Ointments
    • Antibiotics
    • Others
  • Surgery
    • Gingival Grafting
    • Others

By Distribution Channel

  • Hospitals
  • Homecare
  • Pharmacies
  • Others

Growth Drivers

  • Growing Prevalence of NUG and Other Oral Diseases
  • High Cases of Diabetes and Other Lifestyle Diseases
  • Growing Government Initiatives to Curb Tobacco Consumption

Challenges

  • Lack of Awareness Regarding Oral Health Hygiene

Top Featured Companies Dominating the Market

  • Novartis International AG
    • Company Overview
    • Business Strategy
    • Key Product Offerings
    • Financial Performance
    • Key Performance Indicators
    • Risk Analysis
    • Recent Development
    • Regional Presence
    • SWOT Analysis
  • Teva Pharmaceutical Industries Ltd.
  • Mylan N.V.
  • Sanofi S.A.
  • GlaxoSmithKline plc
  • Merck & Co., Inc.
  • Otsuka Pharmaceutical Co., Ltd.,
  • Abbott Laboratories
  • Eli Lilly and Company
  • Hindustan Antibiotics Limited

FREQUENTLY ASKED QUESTIONS


Related Reports


Disclaimer | Privacy Policy | Terms & Conditions

Copyright © 2021 Research Nester. All Rights Reserved